We are live on ! Find out more
INSM icon

Insmed
INSM

146 hedge funds and large institutions have $2.3B invested in Insmed in 2017 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 66 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

330% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 10

187% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 23

137% more capital invested

Capital invested by funds: $970M → $2.3B (+$1.33B)

28% more funds holding

Funds holding: 114 → 146 (+32)

5.04% more ownership

Funds ownership: 91.04% → 96.08% (+5%)

9% more call options, than puts

Call options by funds: $65.6M | Put options by funds: $60.4M

Holders
146
Holders Change
+32
Holders Change %
+28.07%
% of All Funds
3.64%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.12%
New
43
Increased
66
Reduced
23
Closed
10
Calls
$65.6M
Puts
$60.4M
Net Calls
+$5.26M
Net Calls Change
+$20.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$48.9M
2
BlackRock
BlackRock
New York
+$44.1M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$44M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$41.4M
5
RG
Redmile Group
California
+$37.7M

Top Sellers

1
O
OrbiMed
New York
-$48M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10.4M
3
GPP
Great Point Partners
Connecticut
-$9.24M
4
EA
Emerald Advisers
Pennsylvania
-$8.04M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$6.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
51
Sphera Funds Management
Israel
$4.21M +$2.57M +135,000 New
OM
52
Opaleye Management
Massachusetts
$3.75M +$2.29M +120,000 New
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$3.71M +$172K +9,005 +8%
Citigroup
54
Citigroup
New York
$3.68M +$1.33M +69,660 +145%
Swiss National Bank
55
Swiss National Bank
Switzerland
$3.65M +$381K +20,000 +21%
CIP
56
Chartwell Investment Partners
Pennsylvania
$3.5M -$548K -28,793 -20%
Point72 Asset Management
57
Point72 Asset Management
Connecticut
$3.45M +$2.1M +110,410 New
PCM
58
Prelude Capital Management
New York
$3.4M +$2.07M +108,800 New
ECM
59
Endurant Capital Management
California
$2.98M +$1.82M +95,400 New
Barclays
60
Barclays
United Kingdom
$2.94M +$1.63M +85,526 +997%
Jacobs Levy Equity Management
61
Jacobs Levy Equity Management
New Jersey
$2.91M +$1.43M +75,008 +413%
HI
62
HBK Investments
Texas
$2.88M +$1.17M +61,315 +197%
JGC
63
J. Goldman & Co
New York
$2.74M -$1.09M -57,300 -39%
PVI
64
Pura Vida Investments
New York
$2.73M +$1.67M +87,601 New
EI
65
EAM Investors
California
$2.7M +$1.65M +86,522 New
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$2.66M +$236K +12,392 +17%
CS
67
Credit Suisse
Switzerland
$2.59M -$72.2K -3,792 -4%
UOC
68
UBS O'Connor
Illinois
$2.59M +$1.58M +82,858 New
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$2.58M – – –
AQR Capital Management
70
AQR Capital Management
Connecticut
$2.5M +$1.28M +67,311 +523%
WMSA
71
Weiss Multi-Strategy Advisers
New York
$2.34M +$1.43M +75,000 New
Parallax Volatility Advisers
72
Parallax Volatility Advisers
California
$2.31M +$1.41M +73,869 New
QI
73
QS Investors
New York
$2.24M -$26.9K -1,413 -2%
Axa
74
Axa
France
$2.21M -$5.79M -304,039 -81%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$2.09M -$266K -13,944 -17%
1 2
3
4 5

INSM Hedge Fund Activity: Q3 2017 in Review

146 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2017, worth a combined $2.3B — up 137% from $970M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new INSM positions and 10 closed out — a net gain of 33 holders — while 66 added to existing stakes and 23 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $48.9M. The largest seller was OrbiMed, cutting an estimated $48M.

  • 146 institutional investors held Insmed (INSM) as of Q3 2017, up from 114 in Q2 2017.
  • Funds reported $2.3B of Insmed stock for Q3 2017, up 137% quarter-over-quarter.
  • 43 funds opened new Insmed positions in Q3 2017 and 10 closed out, a net change of +33 holders.
  • The largest Insmed buyer in Q3 2017 was T. Rowe Price Associates, an estimated $48.9M added.
  • The largest Insmed seller in Q3 2017 was OrbiMed, an estimated $48M sold.

Based on aggregated 13F filings for Q3 2017.